Sinclair, formally Sinclair Pharma (“Sinclair”, www.sinclair.com) a global aesthetics company headquartered in London and fully owned subsidiary of Huadong Medicine Corporation Limited presents Sculpt&Shape® at the AMWC 2023 congress in Mónaco.
Sculpt&Shape® is an innovative RotateRF technology device for full body contouring and face rejuvenation. Its different tips and modes combined with the real time temperature control and safe touch technology ensure a unique experience for all patients with no downtime. 360º tips RotateRF Technology effectively and evenly heats treatment areas, providing homogeneous heating, facilitating the movement of the applicator, enhancing lymphatic drainage and improving the displacement of the retained interstitial fluids. Sculpt&Shape® is an excellent choice to complete a clinic product portfolio with innovative technology that can be used alone and in combination with other medical aesthetics treatments.
This is another milestone for the company that acquired Cocoon Medical in April 2021 and, in February 2022, added the exciting range of energy-based devices from Viora to its portfolio. Sinclair now has a wide range of products, both injectable fillers and energy-based devices, offering patients a wide variety of aesthetic procedures. The company is on a mission to transform customer confidence with patient safety and satisfaction at the core of everything we do.
Miguel Pardos, CEO of Sinclair commented: “We are delighted to be exhibiting at the AMWC Mónaco 2023 congress and I am looking forward to welcoming our customers and business partners to our booth where they will be able to see our new brand design, our products and meet the global team present”
To see the new brand and see the transformation of the Sinclair training platform visit https://sinclair.com/brands/energy-devices/sculpt-shape/; www.linkedin.com/company/sinclair-pharmaceuticals-ltd; and on Instagram @sinclair.global and @sinclair_ebd_global
FURTHER INFORMATION
